Marc Bickle, Dr. (he/him/his) – Roche

Andrew Alt, PhD – University of Michigan

Robert Damoiseaux – UCLA

Amy Siu, MS – Remix Therapeutics

Ritu Singh, PhD – Broad Institute

Diane Ramsden – AstraZeneca -

John T. Bradshaw, PhD – Artel

Karlton Moore, MBS – Artel

Catherine Heywood – Invitae

Kristen Nailor – Genentech, Inc

Shannon Mumenthaler, PhD – Lawrence J. Ellison Institute for Transformative Medicine of USC

Beth Cimini, PhD – Broad Institute

Kenda Evans, Ph.D. – Agilent Technologies

Andrew Napper, PhD – Bristol Myers Squibb

Breanna Zerfas, PhD – Dana-Farber Cancer Institute‘s Center for Protein Degradation

Ellen Vieux, PhD – C4 Therapeutics

Kristin M. Riching, PhD – Promega Corporation

Hannah Maple, PhD – Bio-Techne

Joe Baldick, PhD – Bristol Myers Squibb

Burkhard Schaefer, Dipl Inf – Burkhard Schaefer

Dana Vanderwall, PhD – Schrodinger

Debbie Bowers, MBA – BioDot, Inc.

Ginger Cooper – Agilent Technologies

Colin Cox, PhD – Seer, Inc.

Mykle C. Gaynor – Dascena

Marcie Glicksman, PhD – EnClear Therapies Inc

Ilyas Singec, MD PhD – NIH/NCATS

Michael Ward

Karl Koehler, PhD – Boston Children's Hospital-Harvard Medical School

Raymond Price, PhD, MBA – Sapient

Adam Long – Scientist.com